Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
3.47% $10.73
America/New_York / 18 apr 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 66.68 mill |
EPS: | -0.540 |
P/E: | -19.87 |
Earnings Date: | Aug 11, 2023 |
SharesOutstanding: | 6.21 mill |
Avg Daily Volume: | 0.0168 mill |
RATING 2024-04-18 |
---|
A |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Neutral | |
Return On Asset: | Strong Buy | |
DE: | Neutral | |
P/E: | Buy | |
Price To Book: | Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
1/22 | 2/22 | 3/22 | 1/23 | 2/23 | 3/23 | |
Revenue | n/a | n/a | ||||
Gr.Profit | n/a | n/a | ||||
Ebit | n/a | n/a | ||||
Asset | n/a | n/a | ||||
Debt | n/a | n/a | n/a | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -19.87 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.42x |
Company: PE -19.87 | industry: PE 47.78 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 10.38 - 11.08 ( +/- 3.23%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-03-07 | Mahajan Umesh | Buy | 0 | |
2022-09-01 | Gordon Scott | Buy | 1 328 | Common Stock |
2022-09-01 | Gentile Gregory M. | Buy | 1 147 | Common Stock |
2022-08-29 | Gordon Scott | Buy | 249 | Common Stock |
2022-08-29 | Gentile Gregory M. | Buy | 2 300 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 9 transactions |
Buy: 13 522 171 | Sell: 0 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $10.73 (3.47% ) |
Volume | 0.0407 mill |
Avg. Vol. | 0.0168 mill |
% of Avg. Vol | 242.08 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Silver Spike Investment Corp., is a a business development company. It is a specialty finance company, focuses on investing across the cannabis ecosystem through investments in the form of direct loans to, and equity ownership of, privately held cannabis companies. It intends to partner with private equity firms, entrepreneurs, business owners, and management teams to provide credit and equity financing alternatives to support buyouts, recapitalizations, growth initiatives, refinancings, and acquisitions across cannabis companies, including cannabis-enabling technology companies, cannabis-related health and wellness companies, and hemp and CBD distribution companies. The company was founded in 2021 and is based in New York, New York.